v3.25.2
Marketable Securities - Summary of Marketable Securities (Details) - IKENA ONCOLOGY INC - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Dec. 31, 2023
Marketable Securities [Line Items]      
Amortized Cost $ 37,287 $ 84,925 $ 55,624
Gross Unrealized Gains 70 103 27
Gross Unrealized Losses (5) (35) (80)
Fair Value 37,352 84,993 55,571
U.S. Treasury Securities      
Marketable Securities [Line Items]      
Amortized Cost   26,985  
Gross Unrealized Gains   19  
Fair Value   27,004  
Corporate Debt Securities      
Marketable Securities [Line Items]      
Amortized Cost 37,287 57,940 55,624
Gross Unrealized Gains 70 84 27
Gross Unrealized Losses (5) (35) (80)
Fair Value $ 37,352 $ 57,989 $ 55,571